<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001687" GROUP_ID="PREG" ID="520399100610015363" MERGED_FROM="" MODIFIED="2008-10-30 17:35:27 +0100" MODIFIED_BY="Frances Kellie" NOTES="&lt;p&gt;Short title (no longer in use): Salt intake during pregnancy&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-09-22 11:55:42 +0100" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="0266" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2008-10-30 17:35:27 +0100" MODIFIED_BY="Frances Kellie">
<TITLE>Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy</TITLE>
<CONTACT MODIFIED="2008-10-30 17:35:27 +0100" MODIFIED_BY="Frances Kellie"><PERSON ID="7397" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Lelia</FIRST_NAME><LAST_NAME>Duley</LAST_NAME><POSITION>Professor of Obstetric Epidemiology</POSITION><EMAIL_1>l.duley@leeds.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Centre for Epidemiology and Biostatistics</DEPARTMENT><ORGANISATION>University of Leeds</ORGANISATION><ADDRESS_1>Bradford Royal Infirmary, Bradford Institute of Health Research</ADDRESS_1><ADDRESS_2>Temple Bank House, Duckworth Lane</ADDRESS_2><CITY>Bradford</CITY><ZIP>BD9 6RJ</ZIP><REGION>West Yorkshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1274 383410</PHONE_1><FAX_1>+44 1274 382767</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2008-10-30 17:35:27 +0100" MODIFIED_BY="Frances Kellie"><PERSON ID="7397" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Lelia</FIRST_NAME><LAST_NAME>Duley</LAST_NAME><POSITION>Professor of Obstetric Epidemiology</POSITION><EMAIL_1>l.duley@leeds.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Centre for Epidemiology and Biostatistics</DEPARTMENT><ORGANISATION>University of Leeds</ORGANISATION><ADDRESS_1>Bradford Royal Infirmary, Bradford Institute of Health Research</ADDRESS_1><ADDRESS_2>Temple Bank House, Duckworth Lane</ADDRESS_2><CITY>Bradford</CITY><ZIP>BD9 6RJ</ZIP><REGION>West Yorkshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1274 383410</PHONE_1><FAX_1>+44 1274 382767</FAX_1></ADDRESS></PERSON><PERSON ID="4691" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>David</FIRST_NAME><MIDDLE_INITIALS>J</MIDDLE_INITIALS><LAST_NAME>Henderson-Smart</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>dhs@mail.usyd.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>NSW Centre for Perinatal Health Services Research</DEPARTMENT><ORGANISATION>Queen Elizabeth II Research Institute</ORGANISATION><ADDRESS_1>Building DO2</ADDRESS_1><ADDRESS_2>University of Sydney</ADDRESS_2><CITY>Sydney</CITY><ZIP>2006</ZIP><REGION>NSW</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 2 93517318</PHONE_1><PHONE_2>+61 2 93517728</PHONE_2><FAX_1>+61 2 93517742</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-09-22 11:49:33 +0100" MODIFIED_BY="Lixia Dou" NOTES="&lt;p&gt;Minor update: 8/16/05&lt;/p&gt;&lt;p&gt;Reformatted: 10/6/99&lt;/p&gt;" NOTES_MODIFIED="2008-09-22 11:49:33 +0100" NOTES_MODIFIED_BY="Lixia Dou">
<UP_TO_DATE>
<DATE DAY="11" MONTH="5" YEAR="1999"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="11" MONTH="5" YEAR="1999"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="9" YEAR="2000"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="1999"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="1999"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="1999"/>
</DATES>
<WHATS_NEW>
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="20" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-09-22 11:53:58 +0100" MODIFIED_BY="[Empty name]"/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Centre for Perinatal Health Services Research, University of Sydney</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Department for Interenational Development</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Medical Research Council</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-09-22 11:55:42 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-09-22 11:53:21 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-09-22 11:53:05 +0100" MODIFIED_BY="[Empty name]">Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy</TITLE>
<SUMMARY_BODY MODIFIED="2008-09-22 11:53:21 +0100" MODIFIED_BY="[Empty name]">
<P>To be prepared. </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>In the past women have been advised that lowering their salt intake might reduce their risk of pre-eclampsia. Although this practice has largely ceased, it remains important to assess the evidence about possible effects of advice to alter dietary salt intake during pregnancy.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>The objective of this review was to assess the effects of dietary advice to alter salt intake compared to continuing a normal diet, on the risk of pre-eclampsia and its consequences.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>We searched the register of trials maintained and updated by the Cochrane Pregnancy and Childbirth Group, and the Cochrane Controlled Trials Register Disc Issue 4, 1998.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Studies were included if they were randomised trials of advice to either reduce or to increase dietary salt during pregnancy.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>All data were extracted independently by both reviewers.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Two trials were included, with 603 women. They compared advice about a low salt diet with no dietary advice. The confidence intervals for all of the outcomes reported were wide, and cross the no effect line. This includes pre-eclampsia (relative risk 1.11, 95% confidence interval 0.46 to 2.66). Even when taken together, these trials are insufficient to provide reliable information about the effects of advice on salt restriction during normal pregnancy. </P>
<P>None of the trials included women with pre-eclampsia, so this review provides no reliable information about changes in salt intake for treatment of pre-eclampsia.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>Salt consumption during pregnancy should remain a matter of personal preference.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-09-22 11:55:42 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND>
<P>In the early part of this century a low salt diet was often recommended as treatment for oedema, in both pregnant and non-pregnant people. At that time oedema was included in the definition of pre-eclampsia, although it is now recognised to be part of normal pregnancy, occurring in 80% of pregnant women. This led to the idea that restricting salt intake would treat, and also prevent, pre-eclampsia (<LINK REF="REF-Green-1989" TYPE="REFERENCE">Green 1989</LINK>). By the 1940s a low salt diet was standard during pregnancy, particularly for women with pre-eclampsia. In the late 1950s and early 1960s this practice began to be questioned, and it was even suggested that high salt intake might prevent or treat pre-eclampsia (<LINK REF="STD-UK-1958" TYPE="STUDY">UK 1958</LINK>, <LINK REF="STD-UK-1961" TYPE="STUDY">UK 1961</LINK>). Subsequently, interest in salt consumption during pregnancy has largely faded away.</P>
<P>In most parts of the world women are no longer advised by clinicians to alter their salt intake during pregnancy. A notable exception is in the Netherlands where this practice has, until recently, remained widespread. Nevertheless, some lay literature aimed at pregnant women continues to advocate salt restriction during pregnancy. </P>
<P>Salt is a widely used flavour enhancer. Those who are used to salt in their diet may find a low salt diet unpalatable. This may be particularly relevant during the first half of pregnancy when nausea and vomiting is common, and taste can also be altered. Low salt foods can also be less convenient and more expensive than salted alternatives. Women should not be advised to alter their dietary salt during pregnancy unless there is reasonable evidence of benefit.</P>
<P>This review aims to summarise the evidence about the effects of advice to alter dietary salt intake during pregnancy.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To assess the effects of advice to have either a low or a high salt intake, compared to normal dietary salt, during pregnancy on prevention and treatment of pre-eclampsia and its complications.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-09-22 11:55:42 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>All randomised controlled trials of advice to alter salt intake during pregnancy. Quasi randomised trials were excluded, as inadequate concealment of the allocation may have introduced bias. For an intervention such as dietary advice where foreknowledge of the allocation may influence recruitment, adequate concealment of the allocation is of particular importance in avoiding bias.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Normal pregnant women, regardless of their risk of pre-eclampsia, and women with pre-eclampsia.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Any study evaluating dietary advice to alter salt intake during pregnancy.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>For the woman: pregnancy-induced hypertension, pre-eclampsia (hypertension with proteinuria), placental abruption, caesarean section, serious maternal morbidity, admission to hospital and use of other hospital resources.<BR/>For the baby: death, prematurity, birthweight, intrauterine growth restriction, admission to special care nursery, ventilation, measures of long term growth and development.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-09-22 11:55:42 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2008-09-22 11:55:42 +0100" MODIFIED_BY="[Empty name]">
<P>The register of trials maintained by the Pregnancy and Childbirth Group was searched for relevant trials. The Cochrane Controlled Trial Register, Disc Issue 4 1998, was also searched.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>Trials were checked for inclusion criteria and data were extracted independently by both reviewers. Discrepancies were resolved by discussion. There was no blinding of authorship or results. A quality score for concealment of allocation was assigned to each trial, using the following criteria:</P>
<P>(A) adequate concealment of allocation <BR/>(B) unclear whether adequate concealment of allocation<BR/>(C) inadequate concealment of allocation, quasi-randomisation. </P>
<P>Studies were excluded if either it was not possible to enter data based on intention to treat, or &gt;20% of participants were excluded from that outcome.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>The two included trials, involving 603 women, were conducted in the Netherlands. The women in the studies were all healthy and nulliparous. Neither study included women with pre-eclampsia, although one (<LINK REF="STD-Netherlands-1998" TYPE="STUDY">Netherlands 1998</LINK>) included women with mild hypertension. Both compared low dietary salt (20 or 50mmol/day) with an unchanged diet. Compliance was assessed by checking urinary sodium excretion. Although this was higher than the target level for the low sodium group, sodium excretion was still lower than for the normal diet group. </P>
<P>There was no blinding of the intervention and, although it is not mentioned in the reports, blinding of outcome assessment is unlikely.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>For both trials allocation was adequately concealed. One (<LINK REF="STD-Netherlands-1997" TYPE="STUDY">Netherlands 1997</LINK>) was conducted in two centres, and subsets of data from both hospitals have been published in a wide variety of formats. Ten per cent of women in this study were excluded from the analyses, and the proportion was higher in the low salt group as 17 women did not want to use the recommended diet. The other study (<LINK REF="STD-Netherlands-1998" TYPE="STUDY">Netherlands 1998</LINK>) involved eight centres and there was complete follow-up for all women.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>Two trials were included, with data reported for 603 women. Both compared advice to restrict dietary salt with advice to continue a normal diet. Confidence intervals for all the outcomes reported in this review are wide, and cross the no effect line. For example, the relative risk for pre-eclampsia is 1.11, 95% confidence interval 0.44-2.78. This means that the true effect could be anything from over a halving in the risk of pre-eclampsia associated with salt restriction to a more than doubling.</P>
<P>No included trials evaluated a high salt diet, and none included women with established pre-eclampsia.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>The aim of this review was to evaluate the effect of advice about dietary salt during pregnancy. Both trials evaluated advice on a low salt diet, and in both the low salt group did have lower urinary excretion than the normal diet group.</P>
<P>The trials in this review were not large and, even when taken together, they are insufficient to provide reliable information about the effects of advice to restrict salt intake during normal pregnancy. None of the trials enrolled women with pre-eclampsia, so this review provides no information about the effects of advice to restrict salt intake for treatment of pre-eclampsia.</P>
<P>Women's preferences were not reported. However, in one study (<LINK REF="STD-Netherlands-1997" TYPE="STUDY">Netherlands 1997</LINK>) 13% of women in the salt restriction arm were excluded as they did not want to follow the diet. In the other study only 24% of women successfully reduced their urinary sodium excretion to below the target level. This was presumed to be because a low salt diet is not very palatable and is therefore difficult to follow.</P>
<P>Although no included trials evaluated a high salt diet, three excluded studies did. In one study this was to evaluate prevention of pre-eclampsia (<LINK REF="STD-UK-1958" TYPE="STUDY">UK 1958</LINK>), and in the other two salt was used for treatment of pre-eclampsia (<LINK REF="STD-UK-1961" TYPE="STUDY">UK 1961</LINK>, <LINK REF="STD-USA-1961" TYPE="STUDY">USA 1961</LINK>). All were excluded because the use of a quasi randomised design introduced substantial potential for bias. In the largest trial (2077 women) the relative risk for pre-eclampsia was 0.45, 95% confidence interval (0.26-0.75), a reduction that appeared to be reflected in fewer complications (<LINK REF="STD-UK-1958" TYPE="STUDY">UK 1958</LINK>). The excluded trials of salt for treatment of pre-eclampsia involved nearly 1000 women, and neither detected any effect on the course of pre-eclampsia. In view of the methodological limitations of these studies it is difficult to draw firm conclusions, beyond saying that it seems unlikely that a high salt diet will increase the risk of pre-eclampsia.</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>A low salt diet is often unpalatable. In the absence of evidence that advice to reduce salt intake during pregnancy has any beneficial effect in prevention or treatment of pre-eclampsia, or of any other outcome, salt consumption during pregnancy should remain a matter of personal preference.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Salt restriction during pregnancy does not seem promising for the prevention of pre-eclampsia. Very large numbers of women would need to be randomised to detect a moderate-small effect. Such trials might be justified in the context of a setting where this form of dietary advice was already widespread practice, but they would be difficult to justify elsewhere. Unless new and plausible hypotheses emerge, further trials of salt intake are unlikely to be a priority.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>None.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>Data were extracted and checked by both reviewers. The text was drafted by Lelia Duley, with comments from David Henderson-Smart.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES>
<P>This review is being updated by the publication of two reviews: one review will evaluate salt intake for preventing pre-eclampsia (see 'Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy') and the other will evaluate salt intake for treating pre-eclampsia. The latter is currently being prepared. Once it has been published, this review will be withdrawn.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES>
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Netherlands-1997" NAME="Netherlands 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;[6671]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steegers EAP, Van Lakwijk HPJM, Jongsma HW, Fast JH, De Boo T, Eskes TKAB et al</AU>
<TI>(Patho)physiological implications of chronic dietary sodium restriction during pregnancy; a longitudinal prospective randomized study</TI>
<SO>Br J Obstet Gynaecol</SO>
<YR>1991</YR>
<VL>98</VL>
<PG>980-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[8893]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van der Maten GD</AU>
<TI>Low sodium diet in pregnancy: effects on maternal nutritional status</TI>
<SO>Eur J Obstet Gynecol Reprod Biol</SO>
<YR>1995</YR>
<VL>61</VL>
<PG>63-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[9022]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Buul BJA, Steegers EAP, Jongsma HW, Rijpkema AL, Eskes TKAB, Thomas CMG et al</AU>
<TI>Dietary sodium restriction in the prophylaxis of hypertensive disorders of pregnancy: effects on the intake of other nutrients</TI>
<SO>Am J Clin Nutr</SO>
<YR>1995</YR>
<VL>62</VL>
<PG>49-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[10508]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Buul BJA, Steegers EAP, van der Maten GD, Delemarre FMC, Jongsma HW, Oosterbaan HP et al</AU>
<TI>Dietary sodium restriction does not prevent gestational hypertension: a Dutch two-center randomized trial</TI>
<SO>Hyper Preg</SO>
<YR>1997</YR>
<VL>16</VL>
<PG>335-346</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[7184]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Buul E, Rijpkema A, Steegers E, Jonggsma T, Eskes P</AU>
<TI>Chronic dietary sodium restriction in pregnancy reduces calcium intake</TI>
<SO>J Perinat Med</SO>
<YR>1992</YR>
<VL>20 Suppl 1</VL>
<PG>216</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[6369]&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>van Buul EJA, Steegers EAP, Jongsma HW, Thomas CMG, Hein PR</AU>
<TI>Chronic dietary sodium restriction in pregnancy: effects on urinary prostaglandin excretion</TI>
<SO>Proceedings of 2nd European Congress on Prostaglandins in Reproduction</SO>
<YR>1991</YR>
<PG>186</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[9934]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van der Post JA, van Buul BJ, Hart AA, van Heerikhuize JJ, Pesman G, Legros JJ et al</AU>
<TI>Vasopressin and oxytocin levels during normal pregnancy: effects of chronic dietary sodium restriction</TI>
<SO>J Endocrinol</SO>
<YR>1997</YR>
<VL>152</VL>
<PG>345-354</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Netherlands-1998" NAME="Netherlands 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;[10297]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Knuist M, Bonsel GJ, Zondervan HA, Treffers PE</AU>
<TI>Low sodium diet and pregnancy-induced hypertension: a multi-centre randomised controlled trial</TI>
<SO>Br J Obstet Gynaecol</SO>
<YR>1998</YR>
<VL>105</VL>
<PG>430-434</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Australia-1986a" NAME="Australia 1986a" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;[3031]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown MA, Gallery EDM</AU>
<TI>Sodium excretion in human pregnancy: a role for arginine vasopressin</TI>
<SO>Am J Obstet Gynecol</SO>
<YR>1986</YR>
<VL>154</VL>
<PG>914-919</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Australia-1986b" NAME="Australia 1986b" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;[3029]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown MA, Sinosich MJ, Saunders DM, Gallery EDM</AU>
<TI>Potassium regulation and progesterone-aldosterone interrelationships in human pregnancy: a prospective study</TI>
<SO>Am J Obstet Gynecol</SO>
<YR>1986</YR>
<VL>155</VL>
<PG>349-353</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-UK-1958" NAME="UK 1958" YEAR="1958">
<REFERENCE NOTES="&lt;p&gt;[0140]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Robinson M</AU>
<TI>Salt in pregnancy</TI>
<SO>Lancet</SO>
<YR>1958</YR>
<VL>1</VL>
<PG>178-181</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-UK-1961" NAME="UK 1961" YEAR="1961">
<REFERENCE NOTES="&lt;p&gt;[0211]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bower D</AU>
<TI>The influence of dietary salt intake on pre-eclampsia</TI>
<SO>J Obstet Gynaecol Br Cmmwlth</SO>
<YR>1961</YR>
<VL>63</VL>
<PG>123-126</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-USA-1961" NAME="USA 1961" YEAR="1961">
<REFERENCE NOTES="&lt;p&gt;[0227]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mengert WF, Tacchi DA</AU>
<TI>Pregnancy toxemia and sodium chloride - preliminary report</TI>
<SO>Am J Obstet Gynecol</SO>
<YR>1961</YR>
<VL>81</VL>
<PG>601-605</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Green-1989" NAME="Green 1989" TYPE="BOOK_SECTION">
<AU>Green J</AU>
<TI>Diet and the prevention of pre-eclampsia</TI>
<SO>Effective Care in Pregnancy and Childbirth</SO>
<YR>1989</YR>
<PG>281-300</PG>
<ED>Chalmers I, Enkin MW, Keirse MJNC</ED>
<PB>Oxford University Press</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES>
<REFERENCE ID="REF-Duley-1995" NAME="Duley 1995" TYPE="COCHRANE_REVIEW">
<AU>Duley L</AU>
<TI>Low vs high salt intake in pregnancy.</TI>
<SO>Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database.</SO>
<YR>1995</YR>
<NO>2</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Netherlands-1997">
<CHAR_METHODS>
<P>"Closed envelope system", no further information. 28 women (10%) women excluded. Low salt 23 excluded: 17 refused diet, 3 social reasons, 2 medical reasons, 1 fetal trisomy. Normal salt 5 excluded: 2 social reasons, 3 medical reasons.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>270 nulliparous women with a singleton pregnancy after 12 weeks, by dates and ultrasound. Excluded if pre-existing HT, diabetes, renal disease, cardiovascular disease.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Low: diet with about 20mmol sodium per day. Oral and written instruction by dietician, no added salt and ready made foods only if no salt in preparation.<BR/>Normal: no dietary restriction.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Woman: PIH, PE, severe HT, small for gestational age, preterm delivery<BR/>Baby: death.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Mean urinary sodium after randomisation was around 70mmol/day in the low sodium group and 135mmol/day in the normal diet group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Netherlands-1998">
<CHAR_METHODS>
<P>Sealed numbered opaque envelopes. Blocks of 10 stratified by centre.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>361 women booked for midwifery care, nulliparous, DBP &lt;90mmHg at booking visit before 20 weeks. Randomised if DBP &gt;85 x2 in subsequent visit, or weight gain &gt;1kg/week for 3 consecutive weeks, or excess oedema. Excluded if planning to leave the city or risk factors for PIH.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Low: sodium restricted diet, aimed at less than 50mmol/day. Written dietary instructions given by midwife.<BR/>Normal: asked not to change eating habits.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Woman: highest DBP, pre-eclampsia, eclampsia, referrals and admissions for hypertension, time to delivery, abruption, mode of delivery.<BR/>Baby: gestation at delivery (mean), birthweight, Apgar at 5 minutes, paediatric admission, death.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Multicentre study involving 8 midwifery practices. Mean urinary sodium after randomisation 84mmol/day in low sodium group, 124mmol/day for normal diet.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>DBP=diastolic blood pressure, PIH=pregnancy induced hypertension, PE=pre-eclampsia, HT=hypertension</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Australia-1986a">
<CHAR_REASON_FOR_EXCLUSION>
<P>No clinical outcomes reported. </P>
<P>Participants: 58 primigravid women. <BR/>Intervention: one week of either high salt or low salt diet.<BR/>Study design: 'assigned randomly'.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Australia-1986b">
<CHAR_REASON_FOR_EXCLUSION>
<P>No clinical outcomes reported. </P>
<P>Participants: 40 primigravid women. <BR/>Intervention: one week of either high salt or low salt diet.<BR/>Study design: 'assigned randomly'.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-UK-1958">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised trial. Quasi random, using alternate allocation of women attending clinic.</P>
<P>Participants: 2077 women at booking clinic, 58 excluded.<BR/>Intervention: high salt diet with advice to add salt to diet and eat salty food versus low salt with advice to avoid adding salt to food and not to eat salty food.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-UK-1961">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised trial. Allocation by ward and by consultant.</P>
<P>Participants: 739 women with high blood pressure, oedema and proteinuria. Excluded if &lt;24 hours from admission to delivery.<BR/>Interventions: 2g salt versus 10g versus 25g.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-USA-1961">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised trial. Quasi random using alternate allocation.</P>
<P>Participants: 48 women with pre-eclampsia.<BR/>Interventions: 1-2g salt versus 10-12g.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Netherlands-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Netherlands-1998">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Low vs normal salt intake in pregnancy</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.9374780377709437" CI_START="0.4906507229850657" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.975" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.28723678827308413" LOG_CI_START="-0.30922755687601056" LOG_EFFECT_SIZE="-0.010995384301463193" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.942394195133306" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="110" TOTAL_2="132" WEIGHT="100.0" Z="0.07226100739234663">
<NAME>Hypertension</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9374780377709437" CI_START="0.4906507229850657" EFFECT_SIZE="0.975" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.28723678827308413" LOG_CI_START="-0.30922755687601056" LOG_EFFECT_SIZE="-0.010995384301463193" ORDER="15059" O_E="0.0" SE="0.3503661088867048" STUDY_ID="STD-Netherlands-1997" TOTAL_1="110" TOTAL_2="132" VAR="0.12275641025641026" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.4861371031386858" CI_END="2.6608561227487573" CI_START="0.45986847497348243" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.106184364060677" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.4250213921065951" LOG_CI_START="-0.3373663612768587" LOG_EFFECT_SIZE="0.04382751541486817" METHOD="MH" NO="2" P_CHI2="0.4856555772121425" P_Q="0.0" P_Z="0.8217104509629123" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="294" TOTAL_2="309" WEIGHT="100.00000000000001" Z="0.2253455708431635">
<NAME>Pre-eclampsia</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="26.116086316843592" CI_START="0.220553720420394" EFFECT_SIZE="2.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.4169080953309139" LOG_CI_START="-0.6564856119077019" LOG_EFFECT_SIZE="0.38021124171160603" ORDER="15060" O_E="0.0" SE="1.2179217270963407" STUDY_ID="STD-Netherlands-1997" TOTAL_1="110" TOTAL_2="132" VAR="1.4833333333333334" WEIGHT="10.029449352669891"/>
<DICH_DATA CI_END="2.507345043448375" CI_START="0.3690598356753443" EFFECT_SIZE="0.9619565217391305" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.3992141026676229" LOG_CI_START="-0.4329032159630825" LOG_EFFECT_SIZE="-0.01684455664772981" ORDER="15061" O_E="0.0" SE="0.48878983201083476" STUDY_ID="STD-Netherlands-1998" TOTAL_1="184" TOTAL_2="177" VAR="0.23891549987718005" WEIGHT="89.97055064733013"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.316158315398852" CI_START="0.4754663292672591" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0494071146245059" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.36476824121872337" LOG_CI_START="-0.32288023273538347" LOG_EFFECT_SIZE="0.020944004241669922" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.9049656499630769" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="177" WEIGHT="100.0" Z="0.11939092591796195">
<NAME>Referral to hospital, no admission</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.316158315398852" CI_START="0.4754663292672591" EFFECT_SIZE="1.0494071146245059" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.36476824121872337" LOG_CI_START="-0.32288023273538347" LOG_EFFECT_SIZE="0.020944004241669922" ORDER="15062" O_E="0.0" SE="0.4039281175154861" STUDY_ID="STD-Netherlands-1998" TOTAL_1="184" TOTAL_2="177" VAR="0.1631579241196043" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.223251013952982" CI_START="0.555778475317312" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8245341614906833" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="42" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.08751558441889797" LOG_CI_START="-0.2550982769755839" LOG_EFFECT_SIZE="-0.08379134627834302" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.3377214814414138" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="177" WEIGHT="100.0" Z="0.9586770380699">
<NAME>Admission to hospital</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.223251013952982" CI_START="0.555778475317312" EFFECT_SIZE="0.8245341614906833" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="42" LOG_CI_END="0.08751558441889797" LOG_CI_START="-0.2550982769755839" LOG_EFFECT_SIZE="-0.08379134627834302" ORDER="15063" O_E="0.0" SE="0.2012530781490848" STUDY_ID="STD-Netherlands-1998" TOTAL_1="184" TOTAL_2="177" VAR="0.04050280146448164" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.980358187643652" CI_START="0.009303243403273802" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.19243243243243244" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.5999221554700784" LOG_CI_START="-2.0313656163303557" LOG_EFFECT_SIZE="-0.7157217304301386" METHOD="MH" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.2863163217027761" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="177" WEIGHT="99.99999999999999" Z="1.0662374747676586">
<NAME>Placental abruption</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.980358187643652" CI_START="0.009303243403273802" EFFECT_SIZE="0.19243243243243244" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5999221554700784" LOG_CI_START="-2.0313656163303557" LOG_EFFECT_SIZE="-0.7157217304301386" ORDER="15064" O_E="0.0" SE="1.5456314622401113" STUDY_ID="STD-Netherlands-1998" TOTAL_1="184" TOTAL_2="177" VAR="2.3889766170665045" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2731852006368887" CI_START="0.43967357638871785" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7481884057971014" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.10489158178756917" LOG_CI_START="-0.35686963393316495" LOG_EFFECT_SIZE="-0.12598902607279788" METHOD="MH" NO="6" P_CHI2="1.0" P_Q="0.0" P_Z="0.28483051100135226" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="177" WEIGHT="100.0" Z="1.0695309399882709">
<NAME>Caesarean section</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2731852006368887" CI_START="0.43967357638871796" EFFECT_SIZE="0.7481884057971014" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="27" LOG_CI_END="0.10489158178756917" LOG_CI_START="-0.35686963393316484" LOG_EFFECT_SIZE="-0.12598902607279788" ORDER="15065" O_E="0.0" SE="0.27124082386924114" STUDY_ID="STD-Netherlands-1998" TOTAL_1="184" TOTAL_2="177" VAR="0.0735715845332647" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="21.029606186605427" CI_START="0.17601097072485244" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.923913043478261" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="1.3228311398957566" LOG_CI_START="-0.7544602618632541" LOG_EFFECT_SIZE="0.2841854390162514" METHOD="MH" NO="7" P_CHI2="1.0" P_Q="0.0" P_Z="0.5917728313493869" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="206" TOTAL_2="203" WEIGHT="100.0" Z="0.5362687439334756">
<NAME>Perinatal mortality</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="15066" O_E="0.0" SE="0.0" STUDY_ID="STD-Netherlands-1997" TOTAL_1="22" TOTAL_2="26" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="21.029606186605427" CI_START="0.17601097072485244" EFFECT_SIZE="1.923913043478261" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3228311398957566" LOG_CI_START="-0.7544602618632541" LOG_EFFECT_SIZE="0.2841854390162514" ORDER="15067" O_E="0.0" SE="1.2202112521515198" STUDY_ID="STD-Netherlands-1998" TOTAL_1="184" TOTAL_2="177" VAR="1.48891549987718" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.068358615209613" CI_START="0.7332910790958158" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.4869061165236712" LOG_CI_START="-0.13472359841230874" LOG_EFFECT_SIZE="0.17609125905568124" METHOD="MH" NO="8" P_CHI2="1.0" P_Q="0.0" P_Z="0.26682157749685187" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="110" TOTAL_2="132" WEIGHT="100.0" Z="1.1104119299605624">
<NAME>Birthweight &lt;10th centile</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.068358615209613" CI_START="0.7332910790958158" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" LOG_CI_END="0.4869061165236712" LOG_CI_START="-0.13472359841230874" LOG_EFFECT_SIZE="0.17609125905568124" ORDER="15068" O_E="0.0" SE="0.3651483716701107" STUDY_ID="STD-Netherlands-1997" TOTAL_1="110" TOTAL_2="132" VAR="0.13333333333333333" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.6730238594133222" CI_START="0.4234721541867883" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8417119565217391" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.2235021345892082" LOG_CI_START="-0.3731751418400414" LOG_EFFECT_SIZE="-0.07483650362541659" METHOD="MH" NO="9" P_CHI2="1.0" P_Q="0.0" P_Z="0.6229699670951225" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="177" WEIGHT="100.0" Z="0.4916455096546978">
<NAME>Birthweight &lt;2500g</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.673023859413322" CI_START="0.42347215418678835" EFFECT_SIZE="0.8417119565217391" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.22350213458920815" LOG_CI_START="-0.37317514184004136" LOG_EFFECT_SIZE="-0.07483650362541659" ORDER="15069" O_E="0.0" SE="0.35049118577469457" STUDY_ID="STD-Netherlands-1998" TOTAL_1="184" TOTAL_2="177" VAR="0.12284407130575148" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.563116552623698" CI_START="0.45507099503767445" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.08" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.4087683553104343" LOG_CI_START="-0.3419208443365349" LOG_EFFECT_SIZE="0.03342375548694973" METHOD="MH" NO="10" P_CHI2="1.0" P_Q="0.0" P_Z="0.8614479846599948" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="110" TOTAL_2="132" WEIGHT="99.99999999999999" Z="0.17453123613154936">
<NAME>Preterm delivery</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.563116552623698" CI_START="0.45507099503767445" EFFECT_SIZE="1.08" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.4087683553104343" LOG_CI_START="-0.3419208443365349" LOG_EFFECT_SIZE="0.03342375548694973" ORDER="15070" O_E="0.0" SE="0.44095855184409843" STUDY_ID="STD-Netherlands-1997" TOTAL_1="110" TOTAL_2="132" VAR="0.19444444444444445" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1965774248415727E-31" CI_END="3.530607305334159" CI_START="0.5348911239072681" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3742236024844718" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" I2="100.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.5478494154926904" LOG_CI_START="-0.2717346088166639" LOG_EFFECT_SIZE="0.13805740333801325" METHOD="MH" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.5090584022349638" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="177" WEIGHT="100.0" Z="0.6603045699179998">
<NAME>Apgar at 5 min &lt;7</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.53060730533416" CI_START="0.5348911239072682" EFFECT_SIZE="1.374223602484472" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.5478494154926905" LOG_CI_START="-0.2717346088166638" LOG_EFFECT_SIZE="0.13805740333801333" ORDER="15071" O_E="0.0" SE="0.48142771288566566" STUDY_ID="STD-Netherlands-1998" TOTAL_1="184" TOTAL_2="177" VAR="0.2317726427343229" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3950806564121807" CI_START="0.6924551063158076" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9828686200378072" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="46" I2="0.0" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="0.14459931701616305" LOG_CI_START="-0.15960837780333598" LOG_EFFECT_SIZE="-0.007504530393586451" METHOD="MH" NO="12" P_CHI2="1.0" P_Q="0.0" P_Z="0.92296376660692" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="184" TOTAL_2="177" WEIGHT="100.0" Z="0.09670109956319788">
<NAME>Paediatric admission</NAME>
<GROUP_LABEL_1>low salt</GROUP_LABEL_1>
<GROUP_LABEL_2>high/normal salt</GROUP_LABEL_2>
<GRAPH_LABEL_1>low salt</GRAPH_LABEL_1>
<GRAPH_LABEL_2>high/normal salt</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3950806564121807" CI_START="0.6924551063158076" EFFECT_SIZE="0.9828686200378072" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="46" LOG_CI_END="0.14459931701616305" LOG_CI_START="-0.15960837780333598" LOG_EFFECT_SIZE="-0.007504530393586451" ORDER="15072" O_E="0.0" SE="0.17869310578934913" STUDY_ID="STD-Netherlands-1998" TOTAL_1="184" TOTAL_2="177" VAR="0.031931226056643516" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>